Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Celgene
Age
18–82
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants must have a body mass index (BMI) of ≥ 18.0 kg/m2 to ≤ 40.0 kg/m2 inclusive at screening.
Participants must have a body weight ≥ 50 kg at screening.
Participants must be afebrile (febrile is defined as ≥ 38°C or 100.4°F) at screening, check in, and predose.
You may not be if
Participants must not have any history of chronic pruritus or dermatologic syndromes that may be confounded with reactions to mezigdomide.
Participants must not have any history of malignancy of any type other than in situ cervical cancer or surgically excised non-melanomatous skin cancers.
Participants with an inability to tolerate oral medication.
Clareo Health | A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment
